Current Ratio of Eiger BioPharmaceuticals, Inc. from 30 Sep 2014 to 31 Dec 2023
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Eiger BioPharmaceuticals, Inc. quarterly Current Ratio in x history and change rate from 30 Sep 2014 to 31 Dec 2023.
- Eiger BioPharmaceuticals, Inc. Current Ratio for the quarter ending 31 Dec 2023 was 2.35x, a 54% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Eiger BioPharmaceuticals, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2023 | 2.35x | -2.8x | -54% | 31 Dec 2023 |
| Q3 2023 | 4.12x | -0.69x | -14% | 30 Sep 2023 |
| Q2 2023 | 4.65x | +0.05x | +1% | 30 Jun 2023 |
| Q1 2023 | 5.3x | +0.81x | +18% | 31 Mar 2023 |
| Q4 2022 | 5.15x | -0.61x | -11% | 31 Dec 2022 |
| Q3 2022 | 4.81x | -2.49x | -34% | 30 Sep 2022 |
| Q2 2022 | 4.6x | -3.23x | -41% | 30 Jun 2022 |
| Q1 2022 | 4.49x | -3.02x | -40% | 31 Mar 2022 |
| Q4 2021 | 5.76x | -0.91x | -14% | 31 Dec 2021 |
| Q3 2021 | 7.3x | +1.21x | +20% | 30 Sep 2021 |
| Q2 2021 | 7.83x | +1.6x | +26% | 30 Jun 2021 |
| Q1 2021 | 7.5x | +0.46x | +6.6% | 31 Mar 2021 |
| Q4 2020 | 6.67x | -0.79x | -11% | 31 Dec 2020 |
| Q3 2020 | 6.09x | -2.42x | -28% | 30 Sep 2020 |
| Q2 2020 | 6.24x | -1.68x | -21% | 30 Jun 2020 |
| Q1 2020 | 7.04x | -0.47x | -6.2% | 31 Mar 2020 |
| Q4 2019 | 7.46x | +0.68x | +10% | 31 Dec 2019 |
| Q3 2019 | 8.51x | +2.79x | +49% | 30 Sep 2019 |
| Q2 2019 | 7.91x | +1.62x | +26% | 30 Jun 2019 |
| Q1 2019 | 7.51x | +1.8x | +31% | 31 Mar 2019 |
| Q4 2018 | 6.78x | -0.46x | -6.3% | 31 Dec 2018 |
| Q3 2018 | 5.72x | -3.06x | -35% | 30 Sep 2018 |
| Q2 2018 | 6.29x | -3.83x | -38% | 30 Jun 2018 |
| Q1 2018 | 5.71x | -6.49x | -53% | 31 Mar 2018 |
| Q4 2017 | 7.24x | -3.25x | -31% | 31 Dec 2017 |
| Q3 2017 | 8.78x | +1.84x | +27% | 30 Sep 2017 |
| Q2 2017 | 10.11x | +2.91x | +40% | 30 Jun 2017 |
| Q1 2017 | 12.2x | +7.52x | +161% | 31 Mar 2017 |
| Q4 2016 | 10.49x | +5.21x | +99% | 31 Dec 2016 |
| Q3 2016 | 6.94x | +0.14x | +2% | 30 Sep 2016 |
| Q2 2016 | 7.2x | -0.91x | -11% | 30 Jun 2016 |
| Q1 2016 | 4.68x | -10.04x | -68% | 31 Mar 2016 |
| Q4 2015 | 5.28x | -10.84x | -67% | 31 Dec 2015 |
| Q3 2015 | 6.8x | -4.95x | -42% | 30 Sep 2015 |
| Q2 2015 | 8.1x | 30 Jun 2015 | ||
| Q1 2015 | 14.72x | 31 Mar 2015 | ||
| Q4 2014 | 16.12x | 31 Dec 2014 | ||
| Q3 2014 | 11.75x | 30 Sep 2014 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.